Modes of p53 regulation

scientific article (publication date: 15 May 2009)

Modes of p53 regulation is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CELL.2009.04.050
P3181OpenCitations bibliographic resource ID633424
P932PMC publication ID3737742
P698PubMed publication ID19450511
P5875ResearchGate publication ID24435350

P2093author name stringGu W
Kruse JP
P2860cites workA novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulationQ22008779
Translating the Histone CodeQ22065840
Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53Q22253350
PML regulates p53 acetylation and premature senescence induced by oncogenic RasQ22254666
Negative control of p53 by Sir2alpha promotes cell survival under stressQ24291828
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylaseQ24291829
ASPP proteins specifically stimulate the apoptotic function of p53Q24291844
p53 is regulated by the lysine demethylase LSD1Q24292925
SUMO-1 and p53.Q34995629
The p53-Mdm2 module and the ubiquitin system.Q35036580
Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damageQ35071254
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulationQ35089377
Phosphorylation of serine 18 regulates distinct p53 functions in miceQ35545143
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activityQ35610627
p300/CBP and cancerQ35779695
The p53 response to DNA damageQ35848498
Mdmx as an essential regulator of p53 activityQ36113127
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.Q36117542
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.Q36347917
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.Q36423924
Transcriptional regulation by p53: one protein, many possibilitiesQ36436698
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivoQ36436702
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibitionQ36499146
The ARF/oncogene pathway activates p53 acetylation within the DNA binding domainQ36833807
The role of ubiquitination in the direct mitochondrial death program of p53.Q36881193
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouseQ37331246
Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.Q37343700
Ubiquitination of p53 at multiple sites in the DNA-binding domainQ37382534
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilizationQ24292930
Monoubiquitylation promotes mitochondrial p53 translocationQ24295012
Critical role for Daxx in regulating Mdm2Q24297332
The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loopQ24297633
p53 has a direct apoptogenic role at the mitochondriaQ24298888
Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse developmentQ24300985
ARF-BP1/Mule is a critical mediator of the ARF tumor suppressorQ24306428
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosisQ24307994
DBC1 is a negative regulator of SIRT1Q24309055
Negative regulation of the deacetylase SIRT1 by DBC1Q24309090
Regulation of p53 activity through lysine methylationQ24311514
Acetylation is indispensable for p53 activationQ24313477
FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activityQ24314409
Repression of p53 activity by Smyd2-mediated methylationQ24315991
A large-scale RNAi screen in human cells identifies new components of the p53 pathwayQ24319883
Mdm2 promotes the rapid degradation of p53Q24322597
The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complexQ24323508
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53Q24328775
An essential function of the extreme C-terminus of MDM2 can be provided by MDMXQ24328822
Modulation of p53 function by SET8-mediated methylation at lysine 382Q24337822
Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivationQ24338320
hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genesQ24338336
p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damageQ24530584
Regulation of p53 function and stability by phosphorylationQ24554530
Two cellular proteins that bind to wild-type but not mutant p53Q24562261
Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibitionQ24562892
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sitesQ24610054
Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint PathwayQ24648370
Regulation of autophagy by cytoplasmic p53Q24651258
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapyQ24651380
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2Q27642888
Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutationsQ27730815
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domainQ27860534
Regulation of p53 stability by Mdm2Q27860744
p53, the cellular gatekeeper for growth and divisionQ27860990
Surfing the p53 networkQ28032484
Arginine methylation regulates the p53 responseQ28116284
Deacetylation of p53 modulates its effect on cell growth and apoptosisQ28138967
CBP/p300 in cell growth, transformation, and developmentQ28140313
Regulation of HDM2 activity by the ribosomal protein L11Q28184745
Definition of a consensus binding site for p53Q28207794
Tumor suppression by Ink4a-Arf: progress and puzzlesQ28207959
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53Q28214793
Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAsQ28246401
A dynamic role of HAUSP in the p53-Mdm2 pathwayQ28253645
Tumour suppression: disruption of HAUSP gene stabilizes p53Q28254102
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2Q28254119
The ubiquitin ligase COP1 is a critical negative regulator of p53Q28258057
Divorcing ARF and p53: an unsettled caseQ28258356
Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation by p53Q28265932
ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activationQ28265951
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomasQ28269089
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activityQ28270986
Identification of p53 as a sequence-specific DNA-binding proteinQ28282745
ASPP [corrected] and cancerQ28299046
p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60Q28304820
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulationQ28508240
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.Q28590239
Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradationQ28609772
A global map of p53 transcription-factor binding sites in the human genomeQ29614400
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53Q29614430
Cancer. p53, guardian of the genomeQ29615610
Regulating the p53 pathway: in vitro hypotheses, in vivo veritasQ29615658
Post-translational modifications and activation of p53 by genotoxic stressesQ29615659
DNA damage activates p53 through a phosphorylation-acetylation cascadeQ29616294
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53Q29617850
T antigen is bound to a host protein in SY40-transformed cellsQ29618321
p53 ubiquitination: Mdm2 and beyondQ29619502
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient miceQ29619786
p53 in health and diseaseQ29619939
Nucleolar Arf sequesters Mdm2 and activates p53Q29620244
C-terminal ubiquitination of p53 contributes to nuclear exportQ33551236
Kinetics of p53 binding to promoter sites in vivoQ33558659
Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cellsQ33588694
p53 and human cancer: the first ten thousand mutations.Q33767112
Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activityQ33863075
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivoQ33896638
The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivationQ33900545
Stress signals utilize multiple pathways to stabilize p53Q33963268
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.Q34170068
Mutation of mouse p53 Ser23 and the response to DNA damageQ34277066
Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.Q34283106
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.Q34312488
The central region of HDM2 provides a second binding site for p53.Q34335012
The p53 proto-oncogene can act as a suppressor of transformationQ34440370
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapyQ34478557
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.Q34585107
Crippling p53 activities via knock-in mutations in mouse modelsQ34614596
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein networkQ34825957
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23.Q37524264
Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activationQ37543781
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitorsQ38315892
Regulation of the specific DNA binding function of p53Q38324290
Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responsesQ38351593
KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis.Q39859206
MSL2 promotes Mdm2-independent cytoplasmic localization of p53Q39912357
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.Q40157263
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsQ40237209
Binding of p53 to the central domain of Mdm2 is regulated by phosphorylationQ40251109
Excess HDM2 impacts cell cycle and apoptosis and has a selective effect on p53-dependent transcription.Q40290190
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.Q40323754
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cellsQ40410781
The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression.Q40491393
Yin Yang 1 is a negative regulator of p53.Q40542917
Inhibition of p53 degradation by Mdm2 acetylationQ40580015
Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53.Q40911280
Mdm2 and Mdm4 loss regulates distinct p53 activitiesQ41269705
The N terminus of p53 regulates its dissociation from DNA.Q42055738
Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppressionQ42062886
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylationQ42816808
Acetylation of the p53 DNA-binding domain regulates apoptosis inductionQ43019120
SnapShot: p53 posttranslational modificationsQ43118019
Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.Q43594592
Acetylation of p53 inhibits its ubiquitination by Mdm2.Q44209228
Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replicationQ44703400
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo.Q44896717
Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosisQ45345472
The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethalityQ46111122
Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment.Q52590496
Latent and active p53 are identical in conformationQ58002479
Dual-site regulation of MDM2 E3-ubiquitin ligase activityQ79954190
Facilitated search for specific genomic targets by p53 C-terminal basic DNA binding domainQ80826872
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)609-22
P577publication date2009-05-15
P1433published inCellQ655814
P1476titleModes of p53 regulation
P478volume137

Reverse relations

cites work (P2860)
Q3456834214-3-3Gamma inhibition of MDMX-mediated p21 turnover independent of p53.
Q397259802,3,7,8-tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hepatocarcinoma cell line HepG2.
Q3946862153BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms
Q98290896A 3D Cell Culture Model Identifies Wnt/β-Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte Regeneration
Q33976501A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A
Q90304315A CD24-p53 axis contributes to African American prostate cancer disparities
Q47101924A Dual Role of P53 in Regulating Colistin-Induced Autophagy in PC-12 Cells
Q38721370A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.
Q38551928A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak·Bcl-xl Complex and Triggering Transcriptional Regulation
Q45354033A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells
Q47590835A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma
Q35973676A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
Q34509620A Small Ribosomal Subunit (SSU) Processome Component, the Human U3 Protein 14A (hUTP14A) Binds p53 and Promotes p53 Degradation
Q94560972A Systems Biology Approach Identifies Hidden Regulatory Connections Between the Circadian and Cell-Cycle Checkpoints
Q39472408A critical role for noncoding 5S rRNA in regulating Mdmx stability
Q24600216A genome-scale protein interaction profile of Drosophila p53 uncovers additional nodes of the human p53 network
Q33591375A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells
Q34540424A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.
Q37982800A new PICTure of nucleolar stress.
Q47074018A novel TRIM family member, Trim69, regulates zebrafish development through p53-mediated apoptosis
Q39283910A novel approach to cancer treatment using structural hybrids of the p53 gene family.
Q42214198A novel facet of tumor suppression by p53: Induction of tumor immunogenicity.
Q55252904A novel isolation method for cancer prognostic factors via the p53 pathway by a combination of in vitro and in silico analyses.
Q37834073A novel oncoprotein Pirh2: rising from the shadow of MDM2.
Q34333807A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53
Q64101387A novel regulatory circuit between p53 and GFI1 controls induction of apoptosis in T cells
Q92461144A nuclear phosphoinositide kinase complex regulates p53
Q37631219A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression.
Q36037994A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53.
Q52705977A systems biology view of evolutionary genetics: network-driven processes incorporate much more variation than evolutionary genetics can handle. This variation is hard to formalise but allows fast change.
Q33826269A theoretical exploration of birhythmicity in the p53-Mdm2 network
Q34385189ABRO1 suppresses tumourigenesis and regulates the DNA damage response by stabilizing p53.
Q40143097AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10-mediated regulatory pathway
Q33588393AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations
Q24314880AKT-dependent phosphorylation of Niban regulates nucleophosmin- and MDM2-mediated p53 stability and cell apoptosis
Q41167426AKT2 suppresses pro-survival autophagy triggered by DNA double-strand breaks in colorectal cancer cells
Q37546075AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity
Q49247817APTM, a Thiophene Heterocyclic Compound, Inhibits Human Colon Cancer HCT116 Cell Proliferation Through p53-Dependent Induction of Apoptosis
Q42143482ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.
Q39070125ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Q24296257ARF-dependent regulation of ATM and p53 associated KZNF (Apak) protein activity in response to oncogenic stress
Q36443372ATM and KAT5 safeguard replicating chromatin against formaldehyde damage.
Q34517226ATM suppresses SATB1-induced malignant progression in breast epithelial cells
Q42243995ATM-dependent downregulation of USP7/HAUSP by PPM1G activates p53 response to DNA damage
Q42154715ATM-mediated phosphorylation of SOG1 is essential for the DNA damage response in Arabidopsis.
Q33570731Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis
Q37306546Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer
Q36615629Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity
Q37581391Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression
Q27667596Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration
Q24339569Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress
Q27314528Acetylation of the pro-apoptotic factor, p53 in the hippocampus following cerebral ischemia and modulation by estrogen
Q37676920Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode
Q34658173Actin polymerization negatively regulates p53 function by impairing its nuclear import in response to DNA damage.
Q64106414Acting locally - affecting globally: RNA sequencing of gilthead sea bream with a mild Sparicotyle chrysophrii infection reveals effects on apoptosis, immune and hypoxia related genes
Q42792438Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2
Q37141585Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype
Q36304376Activation-Induced Cytidine Deaminase Expression in Human B Cell Precursors Is Essential for Central B Cell Tolerance
Q42409336Aerobic Glycolysis Suppresses p53 Activity to Provide Selective Protection from Apoptosis upon Loss of Growth Signals or Inhibition of BCR-Abl
Q38619367Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling
Q91856583Amniotic Fluid Cells, Stem Cells, and p53: Can We Stereotype p53 Functions?
Q47374613Amorphous silica nanoparticles induce malignant transformation and tumorigenesis of human lung epithelial cells via P53 signaling
Q35690429An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells
Q27681154An Ultrahigh Affinity d -Peptide Antagonist Of MDM2
Q38038498An overview of transcriptional regulation in response to toxicological insult.
Q36769000Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer
Q48152470Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer
Q64237823Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs
Q36294822Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.
Q89065778Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
Q30523071Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.
Q55106818Antifibrogenic Influence of Mentha piperita L. Essential Oil against CCl4-Induced Liver Fibrosis in Rats.
Q38285170Antitumor mechanisms when pRb and p53 are genetically inactivated
Q35874908Apak competes with p53 for direct binding to intron 1 of p53AIP1 to regulate apoptosis.
Q50571545Arabidopsis PHYTOCHROME INTERACTING FACTOR proteins promote phytochrome B polyubiquitination by COP1 E3 ligase in the nucleus.
Q38724393Arsenic trioxide induces ROS activity and DNA damage, leading to G0/G1 extension in skin fibroblasts through the ATM-ATR-associated Chk pathway.
Q38174500Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk
Q42063067Association of SIRT1 and HMGA1 expression in non-small cell lung cancer
Q34960791Association of the circadian factor Period 2 to p53 influences p53's function in DNA-damage signaling
Q27675820Atomic Structure of Dual-Specificity Phosphatase 26, a Novel p53 Phosphatase
Q39148631Attachment-regulated signaling networks in the fibroblast-populated 3D collagen matrix
Q64990362Attenuation of autophagy flux by 6-shogaol sensitizes human liver cancer cells to TRAIL-induced apoptosis via p53 and ROS.
Q30669518Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment
Q24303987Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional Suppression
Q33739952Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma
Q37732086Autophagy and the Cell Cycle: A Complex Landscape.
Q36194770Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition
Q89078129BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation
Q36121723BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair
Q37205871BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.
Q47164914BTK blocks the inhibitory effects of MDM2 on p53 activity
Q34414003Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.
Q38282236Battle against cancer: an everlasting saga of p53.
Q38129174Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy
Q39652443Benzo(a)pyrene induces p73 mRNA expression and necrosis in human lung adenocarcinoma H1299 cells
Q34621019Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma
Q27675410Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
Q34158315Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifs
Q21129361Btg1 is Required to Maintain the Pool of Stem and Progenitor Cells of the Dentate Gyrus and Subventricular Zone
Q35128538Bystander communication and cell cycle decisions after DNA damage
Q42323430C23 promotes tumorigenesis via suppressing p53 activity
Q49166463CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer
Q27317294CEP-1, the Caenorhabditis elegans p53 homolog, mediates opposing longevity outcomes in mitochondrial electron transport chain mutants
Q45997551CITED2 affects leukemic cell survival by interfering with p53 activation.
Q39619078CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid
Q38911627CP-31398 prevents the growth of p53-mutated colorectal cancer cells in vitro and in vivo
Q21245061Cancer as a metabolic disease
Q33755908Cancer stem cell theory and the warburg effect, two sides of the same coin?
Q40859595Cancer-associated S100P protein binds and inactivates p53, permits therapy-induced senescence and supports chemoresistance
Q47110552Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit
Q24310683Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop
Q39286948Caught in the act - protein adaptation and the expanding roles of the PACS proteins in tissue homeostasis and disease
Q28483080Ccdc94 protects cells from ionizing radiation by inhibiting the expression of p53
Q36697632Cell Differentiation and Checkpoint
Q28830783Cell signaling, post-translational protein modifications and NMR spectroscopy
Q60300970Cell type-dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance
Q39321805Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.
Q54646381Cellular localization of human p53 expressed in the yeast Saccharomyces cerevisiae: effect of NLSI deletion.
Q39254584Centrosome aberrations associated with cellular senescence and p53 localization at supernumerary centrosomes
Q36860342Cerebellum Development and Tumorigenesis: A p53-Centric Perspective
Q57801746Chromatin-remodeling factor, RSF1, controls p53-mediated transcription in apoptosis upon DNA strand breaks
Q39112125Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry
Q38696332Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Q27002356Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer
Q35926350Comprehensive Expression Profiling and Functional Network Analysis of p53-Regulated MicroRNAs in HepG2 Cells Treated with Doxorubicin
Q34178769Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest
Q36249459Conformational selection and induced fit for RNA polymerase and RNA/DNA hybrid backtracked recognition
Q36655948Connecting chromatin modifying factors to DNA damage response
Q34487653Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53
Q34011009Controlling the Mdm2-Mdmx-p53 Circuit
Q34621458Cooperative actions of p21WAF1 and p53 induce Slug protein degradation and suppress cell invasion
Q38984847Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters
Q89608997Crotonylation at serine 46 impairs p53 activity
Q64973191Curcumin as an Alternative Epigenetic Modulator: Mechanism of Action and Potential Effects.
Q38961549Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program
Q47779642Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling
Q39534965Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro
Q46311981Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma
Q53228284Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis.
Q49732484Cytotoxic Profiling of Plant Secondary Metabolites on P53 Variant Human Colon Carcinoma Cell Lines
Q35170092DECOD: fast and accurate discriminative DNA motif finding
Q30842780DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression.
Q34783261DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control
Q90595521DNA methylation modifier LSH inhibits p53 ubiquitination and transactivates p53 to promote lipid metabolism
Q38695071Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint
Q34368142Deconstructing nucleotide binding activity of the Mdm2 RING domain
Q41908765Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors
Q36251554Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease
Q90739234Dephosphorylation of p53 Ser 392 Enhances Trimethylation of Histone H3 Lys 9 via SUV39h1 Stabilization in CK2 Downregulation-Mediated Senescence
Q36736875Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.
Q27003153Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Q28117749Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
Q38448653Dichotomous role of pancreatic HUWE1/MULE/ARF-BP1 in modulating beta cell apoptosis in mice under physiological and genotoxic conditions
Q36556345Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy
Q33531524Differences in the transactivation domains of p53 family members: a computational study
Q33923989Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells.
Q61814274Differential Mechanisms of Cell Death Induced by HDAC Inhibitor SAHA and MDM2 Inhibitor RG7388 in MCF-7 Cells
Q35571311Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90.
Q39053392Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines
Q58761872Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
Q35040623Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells
Q38943429Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells
Q90575977Dissenting degradation: Deubiquitinases in cell cycle and cancer
Q35737507Distinct p53 genomic binding patterns in normal and cancer-derived human cells
Q35892477Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells
Q42246401Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function
Q38341405Doubles Game: Src-Stat3 versus p53-PTEN in Cellular Migration and Invasion
Q33816125Downmodulation of tumor suppressor p53 by T cell receptor signaling is critical for antigen-specific CD4(+) T cell responses
Q38796554Dracorhodin perchlorate induces the apoptosis of glioma cells
Q42274730Drosophila p53 Is Required to Increase the Levels of the dKDM4B Demethylase after UV-induced DNA Damage to Demethylate Histone H3 Lysine 9
Q38191796Drugging the p53 pathway: understanding the route to clinical efficacy
Q36387594Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 Activity
Q90542956Dual regulation of p53 by the ribosome maturation factor SBDS
Q24324162Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma
Q42050873Dynamic reprogramming of chromatin: paradigmatic palimpsests and HES factors
Q33679142Dynamics of posttranslational modifications of p53.
Q91750497Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Q34684950E2 ligase dRad6 regulates DMP53 turnover in Drosophila
Q34869507EDD inhibits ATM-mediated phosphorylation of p53.
Q55421291ERβ alters the chemosensitivity of luminal breast cancer cells by regulating p53 function.
Q24630090Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck
Q38152281Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis
Q42381105Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death
Q38934408Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor
Q28535332Electrostatically accelerated encounter and folding for facile recognition of intrinsically disordered proteins
Q47121243Elevated p53 Activities Restrict Differentiation Potential of MicroRNA-Deficient Pluripotent Stem Cells
Q38092575Emerging roles for chromatin as a signal integration and storage platform
Q42182800Emerging roles of p53 in glial cell function in health and disease.
Q39352250Emodin regulates apoptotic pathway in human liver cancer cells
Q45885573Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer
Q34360157Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice
Q28079434Epigenetics of Renal Development and Disease
Q43541896Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival
Q59352774Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression
Q60915934Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
Q34557122Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3'-end processing and function during DNA damage.
Q39710961Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy
Q58743588Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
Q31121002Eukaryotic translation elongation factor 1-alpha 1 inhibits p53 and p73 dependent apoptosis and chemotherapy sensitivity
Q28025433Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes
Q39149681Everolimus enhances the cytotoxicity of bendamustine in multiple myeloma cells through a network of pro-apoptotic and cell-cycle-progression regulatory proteins
Q48292871Evidence for a radiation-responsive 'p53 gateway' contributing significantly to the radioresistance of lepidopteran insect cells
Q53609777Evidence for anti-apoptotic roles of proteasome activator 28γ via inhibiting caspase activity.
Q42476896Exploring a minimal two-component p53 model
Q50117885Expression of TP53 and IL-1α in unicystic ameloblastoma predicts the efficacy of marsupialization treatment
Q92528246Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer
Q37281807Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process.
Q37428803Extensive post-translational modification of active and inactivated forms of endogenous p53.
Q59791984Ferritin heavy subunit enhances apoptosis of non-small cell lung cancer cells through modulation of miR-125b/p53 axis
Q34043533Ferroptosis as a p53-mediated activity during tumour suppression
Q35098597Fine-tuning p53 activity through C-terminal modification significantly contributes to HSC homeostasis and mouse radiosensitivity
Q36937240Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56.
Q47128100Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise
Q27678684Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2
Q33875700From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer
Q29248201Functional activation of mutant p53V172F by platinum analogs in cisplatin-resistant human tumor cells is dependent on serine-20 phosphorylation
Q90392099Functional relationship between p53 and RUNX proteins
Q35273347Functional repair of p53 mutation in colorectal cancer cells using trans-splicing
Q54962657G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1.
Q21285144GSK-3β: A Bifunctional Role in Cell Death Pathways
Q38078490Gene copy-number alterations: a cost-benefit analysis
Q30828205Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies
Q28385996Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles
Q95277612Generation of Transgenic Cloned Buffalo Embryos Harboring the EGFP Gene in the Y Chromosome Using CRISPR/Cas9-Mediated Targeted Integration
Q37619445Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma
Q33557871Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population
Q34574962Genetics of ribosomal proteins: "curiouser and curiouser"
Q36004559Genome-wide studies of the transcriptional regulation by p53.
Q34013555Genomic factors that shape craniofacial outcome and neural crest vulnerability in FASD.
Q34734168Ginsenoside Rg3 inhibits melanoma cell proliferation through down-regulation of histone deacetylase 3 (HDAC3) and increase of p53 acetylation
Q37397215Global Changes in Lipid Profiles of Mouse Cortex, Hippocampus, and Hypothalamus Upon p53 Knockout
Q34533232Global effect of inauhzin on human p53-responsive transcriptome
Q39076121Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1.
Q35354504Glycogen synthase kinase 3β inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway
Q36975008Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway
Q34320186Graded enhancement of p53 binding to CREB-binding protein (CBP) by multisite phosphorylation
Q38867373Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A.
Q42712360HATs on for drug resistance
Q37066459HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis
Q36757053HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence
Q34651638HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes
Q39214706HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells
Q38885415HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status
Q37402028HIPK2 modulates p53 activity towards pro-apoptotic transcription
Q36835624HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures
Q38806847Haem oxygenase 1 expression is associated with prognosis in cholangiocarcinoma patients and with drug sensitivity in xenografted mice
Q50286692Haploinsufficiency of Trp53 dramatically extends the lifespan of Sirt6-deficient mice
Q39344424Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system
Q36476953Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation
Q36580378Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
Q41058668Heterogeneity of p53 dependent genomic responses following ethanol exposure in a developmental mouse model of fetal alcohol spectrum disorder.
Q34274477High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
Q33961759High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays
Q34108945High-throughput transcriptome sequencing identifies candidate genetic modifiers of vulnerability to fetal alcohol spectrum disorders
Q35178908Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epithelium
Q39672349Histone deacetylase inhibitors enhance the anticancer activity of nutlin-3 and induce p53 hyperacetylation and downregulation of MDM2 and MDM4 gene expression
Q36601446How do K-RAS-activated cells evade cellular defense mechanisms?
Q39565523Human EHMT2/G9a activates p53 through methylation-independent mechanism
Q36738940Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
Q28386709Human bronchial epithelial BEAS-2B cells, an appropriate in vitro model to study heavy metals induced carcinogenesis
Q21263027Human single-stranded DNA binding proteins are essential for maintaining genomic stability
Q27004438Hydrogen peroxide sensing, signaling and regulation of transcription factors
Q35515340Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation
Q38765522Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 dynamics and cell fate in response to DNA damage
Q38882325Hyperglycemia promotes p53-Mdm2 interaction but reduces p53 ubiquitination in RINm5F cells.
Q24298359Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts
Q47143807Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma
Q47129006Identification and characterization of a metastatic suppressor BRMS1L as a target gene of p53.
Q44871312Identification of XAF1-MT2A mutual antagonism as a molecular switch in cell-fate decisions under stressful conditions
Q58588134Identification of kinases and interactors of p53 using kinase-catalyzed crosslinking and immunoprecipitation (K-CLIP)
Q34154612Identification of lysine succinylation as a new post-translational modification
Q41436986Identification of novel radiation-induced p53-dependent transcripts extensively regulated during mouse brain development
Q38176221Illuminating p53 function in cancer with genetically engineered mouse models
Q35111076Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.
Q61807497Impaired Expression of Rearranged Immunoglobulin Genes and Premature p53 Activation Block B Cell Development in BMI1 Null Mice
Q28708952Implications of systemic dysfunction for the etiology of malignancy
Q28475341In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML
Q35762987Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice
Q50083521Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice
Q36149306Inauhzin and Nutlin3 synergistically activate p53 and suppress tumor growth
Q36801098Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents
Q37406388Increased apoptosis rate of human decidual cells and cytotrophoblasts in patients with recurrent spontaneous abortion as a result of abnormal expression of CDKN1A and Bax.
Q39508688Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice
Q39336132Induction of ASAP (MAP9) contributes to p53 stabilization in response to DNA damage.
Q28573948Inflammatory cells regulate p53 and caspases in acute pancreatitis
Q36138010Influence of Human p53 on Plant Development
Q34565153Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor
Q90635071Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Q35868154Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1.
Q50421763Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Q89739763Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity
Q41810049Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3.
Q36589313Inhibition of cancer cell proliferation by 5-fluoro-2'-deoxycytidine, a DNA methylation inhibitor, through activation of DNA damage response pathway
Q38796979Inhibition of cell proliferation, migration and invasion by a glioma-targeted fusion protein combining the p53 C terminus and MDM2-binding domain
Q33570316Inositol pyrophosphates mediate the DNA-PK/ATM-p53 cell death pathway by regulating CK2 phosphorylation of Tti1/Tel2
Q34009402Insulin receptor tyrosine kinase substrate enhances low levels of MDM2-mediated p53 ubiquitination.
Q38322114Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Q39418221Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma
Q90604823Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosis
Q39723681Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.
Q33656086Interplay between Mdm2 and HIPK2 in the DNA damage response
Q35922756Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined
Q34990640Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation
Q35510300Intrinsically disordered proteins in cellular signalling and regulation.
Q36006961Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation
Q54303856Involvement of Wnt signaling in the injury of murine mesenchymal stem cells exposed to X-radiation.
Q38162722Ionizing radiation-induced responses in human cells with differing TP53 status
Q35131133JMJD6 promotes colon carcinogenesis through negative regulation of p53 by hydroxylation
Q57805010K120R mutation inactivates p53 by creating an aberrant splice site leading to nonsense-mediated mRNA decay
Q34409029KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes
Q58544657KDM5A Regulates a Translational Program that Controls p53 Protein Expression
Q57590598KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells
Q41949624Keeping p53 in check: a high-stakes balancing act.
Q99712014Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
Q24306115Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation
Q38738109Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells.
Q49651549LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress
Q42253318Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion
Q37765653Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
Q92316046Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation
Q47107585Liraglutide restores chronic ER stress, autophagy impairments and apoptotic signalling in SH-SY5Y cells
Q47138075Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions
Q92423983Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer
Q40652796Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.
Q45393476Loss of Genome Fidelity: Beta HPVs and the DNA Damage Response
Q54198378Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Q64106666Loss of SET reveals both the p53-dependent and the p53-independent functions in vivo
Q34409141Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway
Q37022020Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging
Q28548585Low-Dose, Long-Wave UV Light Does Not Affect Gene Expression of Human Mesenchymal Stem Cells
Q38019558Lysine methylation and the regulation of p53.
Q37970950Lysine methylation: beyond histones
Q38769335Lysines in the tetramerization domain of p53 selectively modulate G1 arrest
Q55245371MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.
Q34386033MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein
Q85072453MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis
Q38907224MDMX exerts its oncogenic activity via suppression of retinoblastoma protein
Q35695025MG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage
Q90571091MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance
Q40459014MKK7 and ARF: new players in the DNA damage response scenery.
Q59326864MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance
Q39078439Maintenance of pluripotency in mouse ES cells without Trp53.
Q34503497Making sense of ubiquitin ligases that regulate p53
Q46063736Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases
Q37465881Mathematical model of dynamic protein interactions regulating p53 protein stability for tumor suppression
Q38059700Mdm2 and MdmX as Regulators of Gene Expression
Q41287457Mdm2 and tumorigenesis: evolving theories and unsolved mysteries
Q40680755Mdm2's dilemma: to degrade or to translate p53?
Q39404029MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress
Q35084991MdmX protein is essential for Mdm2 protein-mediated p53 polyubiquitination
Q39646906Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology
Q28392953Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721
Q35900622Mechanisms of p53 activation and physiological relevance in the developing kidney.
Q38865504Medicinal Chemistry Strategies to Disrupt the p53-MDM2/MDMX Interaction.
Q43871288Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
Q37298047Metabolic regulation by p53 family members.
Q60052866Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) is Underexpressed in Clear Cell Renal Cell Carcinoma Tissue and Transfection and Overexpression in Caki-1 Cells Inhibits Cell Proliferation and Increases Apoptosis
Q64242213MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer
Q36130066MiR-1246: a new link of the p53 family with cancer and Down syndrome
Q38924922MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation
Q40337181MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma
Q38035144MicroRNAs in the p53 network: micromanagement of tumour suppression
Q41281675Mild electrical stimulation at 0.1-ms pulse width induces p53 protein phosphorylation and G2 arrest in human epithelial cells.
Q34328693Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis
Q38587869Mitochondrial dynamics regulating chemoresistance in gynecological cancers
Q28818349Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2
Q37725579Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response
Q91663732Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations
Q28546597Modulation of the disordered conformational ensembles of the p53 transactivation domain by cancer-associated mutations
Q41277033Modulation of the p53 family network by RNA-binding proteins
Q26776299Molecular mechanisms of etoposide
Q50934772Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner.
Q37596373Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
Q38616107Moonlighting proteins in cancer.
Q33997232Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia
Q33818479Mutant TP53 posttranslational modifications: challenges and opportunities.
Q37665360NAD(+) Metabolism in Age-Related Hearing Loss
Q41585790NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
Q41993999NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization.
Q46292577NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Q38061832NRF2 and p53: Januses in cancer?
Q52579667Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.
Q34166515Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.
Q39077362Negative auto-regulators trap p53 in their web.
Q37000550Negative regulation of the acetyltransferase TIP60-p53 interplay by UHRF1 (ubiquitin-like with PHD and RING finger domains 1).
Q36156998Negative regulation of the p300-p53 interplay by DDX24.
Q34142778Negative regulation of the tumor suppressor p53 gene by microRNAs.
Q34153536Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage
Q47299905Neonatal Exposure to 6-n-Propyl-Thiouracil, an Anti-Thyroid Drug, Alters Expression of Hepatic DNA Methyltransferases, Methyl CpG-Binding Proteins, Gadd45a, p53, and PCNA in Adult Male Rats
Q26765483New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity
Q34758670New insights into p53 activation
Q38205171New insights into p53 functions through its target microRNAs
Q38389967New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.
Q24622202Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms
Q41993883Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy.
Q37445903Novel HIV-1 therapeutics through targeting altered host cell pathways
Q26777988Novel Implications of DNA Damage Response in Drug Resistance of Malignant Cancers Obtained from the Functional Interaction between p53 Family and RUNX2
Q24299137Novel nucleolar pathway connecting intracellular energy status with p53 activation
Q42591177Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1)
Q42424178Nucleostemin: Another nucleolar "Twister" of the p53-MDM2 loop
Q24595171Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol
Q34379057OTUD5 regulates p53 stability by deubiquitinating p53.
Q34149922Oncogenes and tumor suppressor genes
Q26749382Oncogenic Intra-p53 Family Member Interactions in Human Cancers
Q38156100Oncoprotein stabilization in brain tumors.
Q59329506Orchestration of protein acetylation as a toggle for cellular defense and virus replication
Q39453113Orphan nuclear receptor PNR/NR2E3 stimulates p53 functions by enhancing p53 acetylation
Q38723764Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
Q38045766Overexpression of p53 protein in human tumors
Q27024861Oxidative stress and pulmonary fibrosis
Q38171333Oxygen regulates molecular mechanisms of cancer progression and metastasis
Q37769295Oxygenomics in environmental stress.
Q36522722P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells.
Q28586356PAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis
Q47701502PANDAR: a pivotal cancer-related long non-coding RNA in human cancers
Q92163668PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
Q46242652PEPD is a pivotal regulator of p53 tumor suppressor
Q38842390PHD1 regulates p53-mediated colorectal cancer chemoresistance.
Q39713494PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage.
Q92459709PTEN arginine methylation by PRMT6 suppresses PI3K-AKT signaling and modulates pre-mRNA splicing
Q42668728PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer
Q54603551Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation.
Q46243356Pelargonidin Modulates Keap1/Nrf2 Pathway Gene Expression and Ameliorates Citrinin-Induced Oxidative Stress in HepG2 Cells
Q52663744Peli1 modulates the subcellular localization and activity of Mdmx.
Q26991867Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
Q92155477Peroxiredoxin 5 Silencing Sensitizes Dopaminergic Neuronal Cells to Rotenone via DNA Damage-Triggered ATM/p53/PUMA Signaling-Mediated Apoptosis
Q51372112Persistent transcriptional responses show the involvement of feed-forward control in a repeated dose toxicity study.
Q37366864Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma
Q37191174Pharmacological activation of p53 in cancer cells
Q36618617Pharmacological blockade of a β(2)AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model
Q35196159Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53
Q35252479Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53
Q35149631Phosphorylation of Tip60 by p38α regulates p53-mediated PUMA induction and apoptosis in response to DNA damage
Q28114977Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response
Q35213271Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein
Q26823798Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs)
Q39763520Pirh2 E3 ubiquitin ligase targets DNA polymerase eta for 20S proteasomal degradation.
Q55346775Plakoglobin restores tumor suppressor activity of p53R175H mutant by sequestering the oncogenic potential of β-catenin.
Q37541596Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53.
Q36508707Polycomb group protein PHF1 regulates p53-dependent cell growth arrest and apoptosis
Q33899450Posttranslational modification of p53: cooperative integrators of function
Q52584348Potential therapeutic targets of TP53 gene in the context of its classically canonical functions and its latest non-canonical functions in human cancer.
Q33595368Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor.
Q33594076Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens
Q37978967Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia
Q46477265Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis
Q92565645Prognostic value of chloride channel accessory mRNA expression in colon cancer
Q35813589Programmed cell death 5 mediates HDAC3 decay to promote genotoxic stress response
Q28239216Proline, glutamic acid and leucine-rich protein-1 is essential for optimal p53-mediated DNA damage response
Q51129826Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a.
Q37800060Protein acetylation within the cellular response to radiation.
Q91825036Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice
Q38266035Proteomics for systems toxicology
Q28591824Puma is required for p53-induced depletion of adult stem cells
Q37341983Punicalagin, a polyphenol in pomegranate juice, downregulates p53 and attenuates hypoxia-induced apoptosis in cultured human placental syncytiotrophoblasts
Q38133962Push back to respond better: regulatory inhibition of the DNA double-strand break response
Q42414248Putting the brakes on p53-driven apoptosis
Q35665695RAD6 regulates the dosage of p53 by a combination of transcriptional and posttranscriptional mechanisms
Q47860453RCC2 is a novel p53 target in suppressing metastasis
Q39597077RNA content in the nucleolus alters p53 acetylation via MYBBP1A.
Q34993091RNA polymerase III transcription in cancer: the BRF2 connection
Q39456968RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Q51097612RUNX3 and p53: How Two Tumor Suppressors Cooperate Against Oncogenic Ras?
Q38766269Radon-induced alterations in p53-mediated energy metabolism of malignantly transformed human bronchial epithelial cells
Q36351105Rap2b siRNA significantly enhances the anticancer therapeutic efficacy of adriamycin in a gold nanoshell-based drug/gene co-delivery system
Q36906255Rap2b, a novel p53 target, regulates p53-mediated pro-survival function
Q34230578Rapid and sensitive detection of an intracellular pathogen in human peripheral leukocytes with hybridizing magnetic relaxation nanosensors
Q42498067Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program
Q41960009Reactivating the ARF-p53 axis in AML cells by targeting ULF.
Q37233582Reactivation of mutant p53 by capsaicin, the major constituent of peppers
Q28537881Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine
Q38433099Real-time and simultaneous monitoring of the phosphorylation and enhanced interaction of p53 and XPC acidic domains with the TFIIH p62 subunit.
Q92860226Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer
Q36756039Reciprocal regulation of RORγt acetylation and function by p300 and HDAC1.
Q39256295Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner
Q26740191Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
Q37861632Redox modulation of p53: mechanisms and functional significance
Q36088612Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells.
Q34771336Regulation of DNA damage responses and cell cycle progression by hMOB2.
Q24294656Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4
Q39322285Regulation of Metabolic Activity by p53.
Q26770579Regulation of Mutant p53 Protein Expression
Q45316783Regulation of TP53 Activity
Q45316786Regulation of TP53 Degradation
Q38170004Regulation of cancer metabolism by O-GlcNAcylation
Q34949637Regulation of cell differentiation by the DNA damage response
Q57594615Regulation of p53 acetylation
Q28510160Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage
Q41838045Regulation of p53 during senescence in normal human keratinocytes.
Q41908224Regulation of p53 in NIH3T3 mouse fibroblasts following hyperosmotic stress
Q37992789Regulation of p53: a collaboration between Mdm2 and Mdmx
Q29976922Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.
Q37394276Regulation of the MDM2-p53 pathway by the nucleolar protein CSIG in response to nucleolar stress
Q38302449Regulation of the Tumor-Suppressor Function of the Class III Phosphatidylinositol 3-Kinase Complex by Ubiquitin and SUMO
Q90706140Regulators of Oncogenic Mutant TP53 Gain of Function
Q28066784Regulatory non-coding RNA: new instruments in the orchestration of cell death
Q49916296Repair kinetics of DNA double-strand breaks and incidence of apoptosis in mouse neural stem/progenitor cells and their differentiated neurons exposed to ionizing radiation
Q24337798Repression of Puma by scratch2 is required for neuronal survival during embryonic development
Q36733743Restoration of DNA-binding and growth-suppressive activity of mutant forms of p53 via a PCAF-mediated acetylation pathway
Q39205536Reviving the guardian of the genome: Small molecule activators of p53.
Q39385222Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress
Q34178921Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
Q34850281Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network
Q37690890Role of Autophagy and Apoptosis in Non-Small-Cell Lung Cancer
Q37612283Role of HDAC1 in senescence, aging, and cancer
Q33828002Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis
Q34085616Role of Pirh2 in mediating the regulation of p53 and c-Myc
Q39283898Role of citrullination modification catalyzed by peptidylarginine deiminase 4 in gene transcriptional regulation.
Q61801121Role of p53 in pseudorabies virus replication, pathogenicity, and host immune responses
Q38203736Role of the lncRNA-p53 regulatory network in cancer
Q42355766Roles of Polo-like kinase 3 in suppressing tumor angiogenesis.
Q92257837Roles of p53 Family Structure and Function in Non-Canonical Response Element Binding and Activation
Q37123340Roles of p53 in herpes simplex virus 1 replication
Q34413441Roles of tumor suppressors in regulating tumor-associated inflammation
Q24339585Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma
Q53283601S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence.
Q34313327S-phase sensing of DNA-protein crosslinks triggers TopBP1-independent ATR activation and p53-mediated cell death by formaldehyde
Q28509658S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
Q51011770SAPK pathways and p53 cooperatively regulate PLK4 activity and centrosome integrity under stress.
Q24310032SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53
Q35064623SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block Reactive Oxygen Species-Induced Apoptosis in Mouse Embryonic Stem Cells
Q24297333SIRT1 regulates autoacetylation and histone acetyltransferase activity of TIP60
Q37525832SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
Q39555703SMG7 is a critical regulator of p53 stability and function in DNA damage stress response.
Q34316449SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity
Q36544196STIP is a critical nuclear scaffolding protein linking USP7 to p53-Mdm2 pathway regulation
Q28594151SUMO-specific protease 2 in Mdm2-mediated regulation of p53
Q24301634SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage
Q34077127Scintillation proximity assay for total p53 protein as an alternative to ELISA.
Q38059701Scission of the p53-MDM2 Loop by Ribosomal Proteins
Q41459790Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA.
Q39484755Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells
Q26828473Self-consumption: the interplay of autophagy and apoptosis
Q35518170Ser46 phosphorylation and prolyl-isomerase Pin1-mediated isomerization of p53 are key events in p53-dependent apoptosis induced by mutant huntingtin.
Q35206381Signaling to p53: ribosomal proteins find their way.
Q36901939Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells
Q28481334Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics
Q41768808Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53
Q38993512SirT3 and p53 Deacetylation in Aging and Cancer
Q34028698Sirt3 protects in vitro-fertilized mouse preimplantation embryos against oxidative stress-induced p53-mediated developmental arrest
Q45738787Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts.
Q50575365Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity.
Q37839534Small changes, big impact: posttranslational modifications and function of huntingtin in Huntington disease.
Q27014977Smoking, p53 mutation, and lung cancer
Q37498910SnoN activates p53 directly to regulate aging and tumorigenesis
Q37007086Sod1 loss induces intrinsic superoxide accumulation leading to p53-mediated growth arrest and apoptosis
Q38262589Squaring up to DNA: pentapeptide repeat proteins and DNA mimicry
Q38838490Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.
Q35178418Starvation promotes REV1 SUMOylation and p53-dependent sensitization of melanoma and breast cancer cells.
Q36870100Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.
Q36119624Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26.
Q91850861Structural States of Hdm2 and HdmX: X-ray Elucidation of Adaptations and Binding Interactions for Different Chemical Compound Classes
Q34475801Structural and molecular basis of interaction of HCV non-structural protein 5A with human casein kinase 1α and PKR.
Q27683532Structural basis for the site-specific incorporation of lysine derivatives into proteins
Q27701526Structural basis of how stress-induced MDMX phosphorylation activates p53
Q28484540Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth
Q27658473Structure of the Taz2 domain of p300: insights into ligand binding
Q36741049Structure, functional regulation and signaling properties of Rap2B.
Q29994717Structures of closed and open conformations of dimeric human ATM
Q27680171Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue
Q34675969Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1.
Q35967111Surf the post-translational modification network of p53 regulation
Q38821561Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis
Q47160964Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis
Q35274495T-cell intracellular antigens function as tumor suppressor genes
Q36719443TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene
Q41499355TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
Q37741025TGFbeta and cancer metastasis: an inflammation link.
Q41991646TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency
Q60916058TP53LNC-DB, the database of lncRNAs in the p53 signalling network
Q38732652TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Q33899861TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage
Q37261753TRIMming p53 for ubiquitination
Q90524104TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage
Q34568811Targeted deletion of p53 in the proximal tubule prevents ischemic renal injury
Q59132125Targeted p53 on Small-Molecules-Induced Ferroptosis in Cancers
Q36020398Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept
Q48570977Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma
Q38247168Targeting p53-MDM2-MDMX loop for cancer therapy
Q38059739Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy
Q33657519Targeting tumor suppressor networks for cancer therapeutics
Q95301002Tau affects P53 function and cell fate during the DNA damage response
Q34624486Tethering function of the caspase cleavage fragment of Golgi protein p115 promotes apoptosis via a p53-dependent pathway
Q51060945The "readers" of unacetylated p53 represent a new class of acidic domain proteins.
Q28507164The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo
Q33870522The DNA damage response: the omics era and its impact
Q33725241The DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA damage
Q91710491The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Q24298474The E3 ligase Smurf1 regulates Wolfram syndrome protein stability at the endoplasmic reticulum
Q39005319The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization
Q47215879The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †.
Q42322261The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination.
Q38329840The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells.
Q36980558The MDM2-p53-pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells
Q34030117The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
Q38888153The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.
Q52715352The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest.
Q57166264The Nucleolus
Q47150239The Oncogenic Role of Tribbles 1 in Hepatocellular Carcinoma Is Mediated by a Feedback Loop Involving microRNA-23a and p53.
Q94322163The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell Cycle and DNA Damage Signaling
Q35232574The RNA surveillance protein SMG1 activates p53 in response to DNA double-strand breaks but not exogenously oxidized mRNA.
Q47307122The Roles of P53 and its Family Proteins, P63 and P73, in the DNA Damage Stress Response in Organogenesis Stage Mouse Embryos.
Q36607243The TP53 fertility network
Q99708992The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing
Q36766027The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells
Q34504101The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells
Q33827703The complex landscape of pancreatic cancer metabolism
Q38486293The critical molecular interconnections in regulating apoptosis and autophagy.
Q37859721The dual role of p53: DNA protection and antioxidant.
Q37665224The effect of epigenetic silencing and TP53 mutation on the expression of DLL4 in human cancer stem disorder
Q34554010The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro
Q37897323The emerging role of Mule and ARF in the regulation of base excision repair
Q26853164The functional diversity of protein lysine methylation
Q38061848The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes
Q34429176The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome
Q39233244The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
Q40562742The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
Q34199692The impact of acetylation and deacetylation on the p53 pathway
Q38786667The importance of p53 pathway genetics in inherited and somatic cancer genomes.
Q28483781The inhibition of autophagy sensitises colon cancer cells with wild-type p53 but not mutant p53 to topotecan treatment
Q35786347The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury
Q34846077The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.
Q37526379The multiple levels of regulation by p53 ubiquitination
Q30356852The next level of complexity: crosstalk of posttranslational modifications.
Q38515093The nucleolar interface of RNA viruses
Q37596345The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption
Q24597470The nucleolus under stress
Q37359180The origin of allosteric functional modulation: multiple pre-existing pathways
Q35122947The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
Q34020353The p53 orchestra: Mdm2 and Mdmx set the tone
Q27690770The p53 pathway as a target in cancer therapeutics: obstacles and promise
Q35046887The p53 response in single cells is linearly correlated to the number of DNA breaks without a distinct threshold
Q58780971The p53/Adipose-Tissue/Cancer Nexus
Q33685413The regulation of the p53-mediated stress response by MDM2 and MDM4.
Q45395590The ribosomal protein S26 regulates p53 activity in response to DNA damage
Q96764448The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation
Q36392179The transcription factor CREBZF is a novel positive regulator of p53.
Q42917239The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism
Q37762069The tumor suppressor p53: from structures to drug discovery
Q24644208The ubiquitin proteasome system in neuropathology
Q48000346The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities
Q38795765The viral non-structural protein 1 alpha (Nsp1α) inhibits p53 apoptosis activity by increasing murine double minute 2 (mdm2) expression in porcine reproductive and respiratory syndrome virus (PRRSV) early-infected cells
Q36833275Therapeutic targeting of the p53 pathway in cancer stem cells.
Q41807243Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells
Q41126970Tia1 dependent regulation of mRNA subcellular location and translation controls p53 expression in B cells.
Q36889843Tissue Inhibitor of Matrix Metalloproteinases-1 Knockdown Suppresses the Proliferation of Human Adipose-Derived Stem Cells
Q34838208Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function
Q39242429Tissue-Specific Functions of p53 During Kidney Development
Q35783751Towards an understanding of the role of p53 in adrenocortical carcinogenesis
Q38838992Toxoplasma gondii Rhoptry Protein ROP16 Mediates Partially SH-SY5Y Cells Apoptosis and Cell Cycle Arrest by Directing Ser15/37 Phosphorylation of p53
Q35138721Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo
Q38541481Transcription factors that interact with p53 and Mdm2
Q24301836Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
Q92636264Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence
Q37777267Transcriptional regulation by p53.
Q34171267Transcriptional repressor NIR functions in the ribosome RNA processing of both 40S and 60S subunits
Q38594197Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2.
Q38919143Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing
Q39505445Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas
Q96135302Trisenox Disrupts MDM2-DAXX-HAUSP Complex and Induces Apoptosis in a Mouse Model of Acute Leukemia
Q35198383Truncating mutations of PPM1D are found in blood DNA samples of lung cancer patients.
Q36161900Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line
Q26992094Tumor suppression in skin and other tissues via cross-talk between vitamin D- and p53-signaling
Q43120565Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence
Q37412688Tumor suppressive functions of p53
Q33833892Tumor suppressor RASSF1A promoter: p53 binding and methylation
Q44608082Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21.
Q28477217Tumor suppressor p53 functions as a negative regulator in IgE-mediated mast cell activation
Q38966981Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Q39708546Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA.
Q37810431Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention
Q38824332Tumor-Suppressor Functions of the TP53 Pathway
Q24295055Turning the RING domain protein MdmX into an active ubiquitin-protein ligase
Q35022037Two-phase dynamics of p53 in the DNA damage response.
Q36771960UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Q38941587UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Q98513730UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination
Q34696209USP11 regulates p53 stability by deubiquitinating p53.
Q52723469USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells.
Q24300434USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1
Q36944526USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation
Q37577477USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis
Q42714232USP7/HAUSP stimulates repair of oxidative DNA lesions
Q36232109UXT, a novel MDMX-binding protein, promotes glycolysis by mitigating p53-mediated restriction of NF-κB activity
Q34503492Ubiquitin becomes ubiquitous in cancer: emerging roles of ubiquitin ligases and deubiquitinases in tumorigenesis and as therapeutic targets
Q39032658Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastoma
Q39221079Ubiquitination/deubiquitination and acetylation/deacetylation: making DNMT1 stability more coordinated
Q36485242Ubiquitylation of p53 by the APC/C inhibitor Trim39.
Q35615172Uncovering ubiquitin and ubiquitin-like signaling networks
Q37802195Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
Q38128769Unraveling DNA damage response-signaling networks through systems approaches
Q52586740Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
Q37380800Uptake, p53 pathway activation, and cytotoxic responses for Co(II) and Ni(II) in human lung cells: implications for carcinogenicity
Q64950512Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer.
Q33895858Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma
Q37748214Using mice to examine p53 functions in cancer, aging, and longevity
Q34209099Validation of MdmX as a therapeutic target for reactivating p53 in tumors
Q35275179Vesicular stomatitis virus expressing tumor suppressor p53 is a highly attenuated, potent oncolytic agent
Q64387425Vitamin C increases DNA breaks and suppresses DNA damage-independent activation of ATM by bleomycin
Q33815907WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway
Q33913340WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death
Q39989125WTX: an unexpected regulator for p53.
Q33947783Wheel running, skeletal muscle aerobic capacity and 1-methyl-1-nitrosourea induced mammary carcinogenesis in the rat.
Q34248659When ribosomes go bad: diseases of ribosome biogenesis
Q39030008Wig-1 regulates cell cycle arrest and cell death through the p53 targets FAS and 14-3-3σ.
Q35146343Wild type p53 reactivation: from lab bench to clinic.
Q38266298Wip1 phosphatase in breast cancer
Q35984061Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio
Q58782264Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
Q89862470Working on Genomic Stability: From the S-Phase to Mitosis
Q34441993XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313
Q36655029hSSB1 regulates both the stability and the transcriptional activity of p53
Q92508193iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition
Q33998215mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes
Q58600725mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
Q33599315miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines
Q58918367p53
Q28085076p53 Acetylation: Regulation and Consequences
Q37378360p53 E3 ubiquitin protein ligase homolog regulates p53 in vivo in the adult mouse eye lens
Q37093496p53 Is a Host Cell Regulator during Herpes Simplex Encephalitis
Q60907996p53 Loss in Breast Cancer Leads to Myc Activation, Increased Cell Plasticity, and Expression of a Mitotic Signature with Prognostic Value
Q64071826p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
Q39242999p53 acetylation enhances Taxol-induced apoptosis in human cancer cells
Q36882319p53 activation by Ni(II) is a HIF-1α independent response causing caspases 9/3-mediated apoptosis in human lung cells
Q84583329p53 ancestry: gazing through an evolutionary lens
Q34001316p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization
Q37874926p53 and Notch signaling in chronic lymphocytic leukemia: clues to identifying novel therapeutic strategies
Q39328814p53 and Sp1 cooperate to regulate the expression of Epstein-Barr viral Zta protein
Q37510423p53 and p73 Regulate Apoptosis but Not Cell-Cycle Progression in Mouse Embryonic Stem Cells upon DNA Damage and Differentiation
Q38255171p53 and the PWWP domain containing effector proteins in chromatin damage repair
Q51761242p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine.
Q34029735p53 at a glance
Q36052576p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes
Q47096055p53 dynamics orchestrates with binding affinity to target genes for cell fate decision.
Q35228392p53 in stem cells
Q38540071p53 in survival, death and metabolic health: a lifeguard with a licence to kill
Q24306453p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma
Q36347218p53 is a major component of the transcriptional and apoptotic program regulated by PI 3-kinase/Akt/GSK3 signaling
Q87895880p53 keeps bystanders at the gates
Q91701515p53 modifications: exquisite decorations of the powerful guardian
Q35063064p53 negatively regulates RGS13 protein expression in immune cells
Q30275107p53 pathway is involved in cell competition during mouse embryogenesis
Q34300569p53 post-translational modification: deregulated in tumorigenesis
Q46251110p53 promotes AKT and SP1-dependent metabolism through the pentose phosphate pathway that inhibits apoptosis in response to Nutlin-3a
Q37882073p53 regulation by ubiquitin
Q40715545p53 requires an intact C-terminal domain for DNA binding and transactivation
Q35169245p53 requires the stress sensor USF1 to direct appropriate cell fate decision.
Q35855525p53 staining correlates with tumor type and location in sebaceous neoplasms
Q36567469p53 sumoylation: mechanistic insights from reconstitution studies
Q39061575p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3.
Q42371457p53 upregulates PLCε-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B.
Q64106681p53 β-hydroxybutyrylation attenuates p53 activity
Q42122625p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation.
Q42362115p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance
Q64921751p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.
Q44935692p53-Pathway activity and apoptosis in hydrogen sulfide-exposed stem cells separated from human gingival epithelium
Q37727778p53-family proteins and their regulators: hubs and spokes in tumor suppression
Q38247164p53-independent effects of Mdm2.
Q34397020p53-mediated apoptosis requires inositol hexakisphosphate kinase-2
Q55322510p73 Alternative Splicing: Exploring a Biological Role for the C-Terminal Isoforms.
Q28611414p73 as a pharmaceutical target for cancer therapy
Q28590571p85α mediates p53 K370 acetylation by p300 and regulates its promoter-specific transactivity in the cellular UVB response
Q37163437β-Catenin C-terminal signals suppress p53 and are essential for artery formation
Q28389986Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pat

Search more.